- US12600715utility2026Soluble Guanylate Cyclate Activators for Treating Systemic Sclerosis0 cites
- US12600770utility2026Antibodies to Connective Tissue Growth Factor (CTGF) and Uses Thereof0 cites
- US12577297utility2026Anti-il-23p19 Antibody Formulations0 cites
- US12559529utility2026NPY2 Receptor Agonists0 cites
- US12540187utility2026Method of Treating Vascular Eye and Retinal Diseases by Administration of Anti-neuropilin 1A Antibodies0 cites
- US12528879utility2026Multi-specific Binding Proteins for Cancer Treatment0 cites
- US12527810utility2026Pharmaceutical Composition, Methods for Treating and Uses Thereof0 cites
- US12527924utility2026Nebulizer and Container0 cites
- US12509655utility2025Integrated and Continuous Recombinant Protein Manufacturing0 cites
- US12503512utility2025Use of Anti-il-36r Antibodies for Treatment of Generalized Pustular Psoriasis0 cites
- US12497401utility2025Substituted Tetrazoles as TRPA1 Inhibitors0 cites
- US12487235utility2025Compositions and Methods for Studying Drug Metabolism0 cites
- US12479827utility2025Heteroaromatic Carboxamide Derivatives as Plasma Kallikrein Inhibitors0 cites
- US12473365utility2025FLT3 Agonist Antibodies and Uses Thereof0 cites
- US12453749utility2025Recombinant Rhabdovirus Encoding for CCL210 cites
- US12448456utility2025Method for Producing Spesolimab0 cites
- US12441785utility2025Methods of Treating Inflammatory Diseases0 cites
- US12433897utility2025Pyridine Derivatives with N-linked Cyclic Substituents as Cgas Inhibitors0 cites
- US12433906utility2025Pharmaceutical Composition, Methods for Treating and Uses Thereof0 cites
Page 1 of 8Next →